211 related articles for article (PubMed ID: 29038278)
1. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
[No Abstract] [Full Text] [Related]
2. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
[TBL] [Abstract][Full Text] [Related]
4.
Li Y; Xu S; Xu Q; Chen Y
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):452-462. PubMed ID: 31918570
[No Abstract] [Full Text] [Related]
5. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells.
Zhao D; Bakirtzi K; Zhan Y; Zeng H; Koon HW; Pothoulakis C
J Biol Chem; 2011 Feb; 286(8):6092-9. PubMed ID: 21212273
[TBL] [Abstract][Full Text] [Related]
7. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
8. Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.
Wang J; Ortiz C; Fontenot L; Mukhopadhyay R; Xie Y; Chen X; Feng H; Pothoulakis C; Koon HW
J Infect Dis; 2020 Apr; 221(10):1623-1635. PubMed ID: 31793629
[TBL] [Abstract][Full Text] [Related]
9. Fidaxomicin inhibits toxin production in Clostridium difficile.
Babakhani F; Bouillaut L; Sears P; Sims C; Gomez A; Sonenshein AL
J Antimicrob Chemother; 2013 Mar; 68(3):515-22. PubMed ID: 23208832
[TBL] [Abstract][Full Text] [Related]
10. Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.
Cowardin CA; Jackman BM; Noor Z; Burgess SL; Feig AL; Petri WA
Infect Immun; 2016 Aug; 84(8):2317-2323. PubMed ID: 27271747
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase/IκB kinase/NF-κB-dependent and AP-1-independent CX3CL1 expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
Ko SH; Jeon JI; Kim H; Kim YJ; Youn J; Kim JM
J Mol Med (Berl); 2014 Apr; 92(4):411-27. PubMed ID: 24362517
[TBL] [Abstract][Full Text] [Related]
12. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
13. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice.
Hing TC; Ho S; Shih DQ; Ichikawa R; Cheng M; Chen J; Chen X; Law I; Najarian R; Kelly CP; Gallo RL; Targan SR; Pothoulakis C; Koon HW
Gut; 2013 Sep; 62(9):1295-305. PubMed ID: 22760006
[TBL] [Abstract][Full Text] [Related]
14. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D
Chan H; Li Q; Wang X; Liu WY; Hu W; Zeng J; Xie C; Kwong TNY; Ho IHT; Liu X; Chen H; Yu J; Ko H; Chan RCY; Ip M; Gin T; Cheng ASL; Zhang L; Chan MTV; Wong SH; Wu WKK
Autophagy; 2022 Sep; 18(9):2050-2067. PubMed ID: 34989311
[No Abstract] [Full Text] [Related]
16. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
17. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.
Moss AC; Anton P; Savidge T; Newman P; Cheifetz AS; Gay J; Paraschos S; Winter MW; Moyer MP; Karalis K; Kokkotou E; Pothoulakis C
Gut; 2007 Sep; 56(9):1210-7. PubMed ID: 17412781
[TBL] [Abstract][Full Text] [Related]
18. NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
Kim JM; Lee JY; Yoon YM; Oh YK; Youn J; Kim YJ
Scand J Immunol; 2006 Jun; 63(6):453-60. PubMed ID: 16764699
[TBL] [Abstract][Full Text] [Related]
19. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling.
Kim DH; Lee IH; Nam ST; Nam HJ; Kang JK; Seok H; Hwang JS; Kim H
J Microbiol Biotechnol; 2014 May; 24(5):696-703. PubMed ID: 24509250
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
Louise CB; Tran MC; Obrig TG
Infect Immun; 1997 Aug; 65(8):3337-44. PubMed ID: 9234795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
